Our Team.

Dr. Dan Paulson is a physician with over 25 years of experience in global drug development. He was previously Vice President of Clinical Development at Capricor Therapeutics and at Bayer Healthcare. During his 13-year tenure with Bayer as Group Head for Established Products and Corporate Social Responsibility, Dr. Paulson oversaw a diverse range of therapeutic areas and led an initiative to repurpose drugs for new therapeutic uses. He and his teams designed and executed numerous development programs leading to successful drug approvals in many regions of the world. Several of these programs were targeting orphan/rare disease indications, and one program obtained a priority review voucher. Prior to joining Bayer, Dr. Paulson was the Director for Cardiothrombosis at Sanofi’s US Clinical Research Unit. His group was instrumental in the completion of many key phase II and III programs for Sanofi leading to several drug approvals.

Dr. Paulson received his MD degree from the Medical College of Virginia in 1992. After completing his internal medicine internship and residency, he served as a Medical Chief Resident for the Internal Medicine Program. He subsequently joined the faculty at Medical College of Virginia where he practiced full-time in the Veterans Affairs Medical Center acting as the director for one of the Primary Care Group practices, and he established a successful clinical research operation within the Primary Care Department. He was the principal investigator for 70+ industry-sponsored clinical trials and VA cooperative studies.